Pancreatic Cancer Research

ResearcherHeidelberg UniversityNo recent work listed

Xinlai Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6441-3742; OpenAlex author ID A5058717978. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 4

  1. Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p. Co-author DOI 10.3389/fonc.2021.653061↗
  2. Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in … Last author DOI 10.3390/molecules22091546↗
  3. A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells. Co-author DOI 10.1186/1476-4598-13-221↗
  4. Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of huma… Co-author DOI 10.1016/j.molonc.2012.10.013↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Danhui Ma · 1 shared paper, 2021 · strength 0.12
  2. Guangqi Song · 1 shared paper, 2021 · strength 0.12
  3. Jana F. Tegethoff · 1 shared paper, 2017 · strength 0.08
  4. Stefan Wölfl · 1 shared paper, 2014 · strength 0.05
  5. Richard Jove · 1 shared paper, 2013 · strength 0.03
  6. Sangkil Nam · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.